Evidence map›Paper›PMID 8645086›Full record

ArticleArchives of virology1996

Heat shock induces HIV-1 replication in chronically infected promyelocyte cell line OM10.1.

K Hashimoto, M Baba, K Gohnai, M Sato, S Shigeta

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of virology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Molecules (Basel, Switzerland) · 2022
    Article
  2. Article
  3. HSF1 Activation Can Restrict HIV Replication.ACS infectious diseases · 2020
    Article
  4. Review
  5. Inhibition of Heat Shock Protein 90 Prevents HIV Rebound.The Journal of biological chemistry · 2016
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

K HashimotoDepartment of Microbiology, Fukushima Medical College, Japan.
M Baba
K Gohnai
M Sato
S Shigeta
Imperial Household Agency · JPKagoshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A long period of clinical latency before development of symptoms is characteristic of human immunodeficiency virus type 1 (HIV-1) infection. OM10.1, a promyelocyte cell line latently infected with HIV-1, has been developed as a model for studying the mechanism of viral latency and the activation of virus expression. We found that this latently infected cell line with heat shock at 42 degrees C for 2 h resulted in a high level of HIV-1 production without addition of any cytokines. The mechanism of activation was analyzed by using anti-TNF-alpha antibody and various inhibitors. Although the TNF-alpha level in culture supernatants was below the sensitivity of an ELISA assay system, addition of anti-TNF-alpha antibody in culture medium could partially suppress the heat shock induced HIV-1 production. Staurosporine (PKC inhibitor), pentoxifylline (NF-kappa B inhibitor), and Ro5-3335 (HIV-1 Tat inhibitor) also inhibited significantly the heat shock induced virus activation. In particular, staurosporine achieved approximately 90% inhibition of the HIV-1 antigen expression in heat shock-treated OM10.1 at a non-toxic concentration. Although the mechanism of HIV-1 activation with heat shock has not been fully elucidated yet, it is presumed PKC plays an important role in HIV-1 activation. Thus, the present observations will provide a further insight into the pathogenesis of HIV-1 infections.

Indexed as

Heat-Shock ResponseVirus ActivationAlkaloidsAntibodiesAntiviral AgentsBenzodiazepinonesCell LineEnzyme InhibitorsGene Products, tatGranulocytesHIV-1HumansNF-kappa BPentoxifyllineProtein Kinase CPyrrolesAlkaloidsAntibodiesAntiviral AgentsBenzodiazepinonesEnzyme InhibitorsGene Products, tatNF-kappa BPentoxifyllineProtein Kinase CPyrrolesRo 5-3335Staurosporinetat Gene Products, Human Immunodeficiency VirusTumor Necrosis Factor-alpha

Identifiers

PMID8645086
OpenAlexW1969021810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.